Affiris Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $10.7M
Latest Deal Amount
  • Investors
  • 6

Affiris General Information

Description

Developer of therapeutic peptide vaccines designed to prevent chronic diseases. The company's vaccines establish treatment options for neurodegenerative diseases to preserve the quality of life of patients, enabling physicians to offer a level of safety and efficacy superior to native sequences.

Contact Information

Website
www.affiris.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Karl-Farkas-Gasse 22
  • Vienna, 1030
  • Austria
+43 01 0000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Affiris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 02-May-2017 $10.7M 000.00 Completed Generating Revenue
6. Later Stage VC 18-May-2015 000.00 000.00 Completed Generating Revenue
5. Grant 12-Oct-2011 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 11-Aug-2011 000.00 000.00 Completed Generating Revenue
3. Grant 16-Dec-2010 00000 000.00 Completed Generating Revenue
2. Grant 01-Jun-2009 $30.7M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Oct-2008 $30.7M $30.7M Completed Generating Revenue
To view Affiris’s complete valuation and funding history, request access »

Affiris Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapeutic peptide vaccines designed to prevent chronic diseases. The company's vaccines establish treatme
Drug Discovery
Vienna, Austria
10 As of 2021
000.00
0000000000 0 000.00

000000

amco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000000000000
Smyrna, GA
0 As of 0000
000.00
00000000 000.00

000000 0

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000000000000
Foster City, CA
00000 As of 0000
00.000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Affiris Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeoVax Corporation Smyrna, GA 0 000.00 00000000 000.00
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000&0
You’re viewing 2 of 2 competitors. Get the full list »

Affiris Executive Team (15)

Name Title Board Seat Contact Info
Noel Barrett Ph.D Board Member & Chief Executive Officer
Gunther Staffler Chief Technology Officer
Cornelia Kutzer Ph.D Chief Business Officer
Martina Hopitzan Head of Finance & Administration
Helmut Jeggle Vice Chairman of Supervisory Board
You’re viewing 5 of 15 executive team members. Get the full list »

Affiris Board Members (11)

Name Representing Role Since
Andrea Lentz-Koblenc Self Board Member 000 0000
Christopher Huber MD Self Board Member 000 0000
Helmut Jeggle Affiris Vice Chairman of Supervisory Board 000 0000
Katja Balazs Self Board Member 000 0000
Michael Motschmann Ph.D MIG AG Chairman, Supervisory Board 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Affiris Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Affiris Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FCPB Affi Other Minority 000 0000 000000 0
ARAX Capital Partners Venture Capital Minority 000 0000 000000 0
MIG AG Venture Capital Minority 000 0000 000000 0
Santo Venture Capital Venture Capital Minority 000 0000 000000 0
EuroTransBio Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »